Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Peripheral Blood Stem Cell Transplantation (PBSCT) After Preparative Therapy Consisting of Cyclophosphamide, BCNU, and Etoposide (CBV) for Recurrent and Primarily Refractory Hodgkin's and Non-Hodgkin's Lymphoma

NCT00002941 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00002941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Peripheral Blood Stem Cell Transplantation (PBSCT) After Preparative Therapy Consisting of Cyclophosphamide, BCNU, and Etoposide (CBV) for Recurrent and Primarily Refractory Hodgkin's and Non-Hodgkin's Lymphoma
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
April 30, 1998
Completion date
March 31, 2007
Enrollment
69 (actual)
Sites
235

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma